Cutler Group’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,100
| Closed | -$5K | – | 2926 |
|
|
2021
Q3 | $5K | Hold |
1,100
| – | – | ﹤0.01% | 1867 |
|
|
2021
Q2 | $5K | Buy |
1,100
+100
| +10% | +$455 | ﹤0.01% | 1876 |
|
|
2021
Q1 | $4K | Sell |
1,000
-200
| -17% | -$800 | ﹤0.01% | 1823 |
|
|
2020
Q4 | $5K | Hold |
1,200
| – | – | ﹤0.01% | 1578 |
|
|
2020
Q3 | $4K | Sell |
1,200
-600
| -33% | -$2K | ﹤0.01% | 1498 |
|
|
2020
Q2 | $4K | Hold |
1,800
| – | – | ﹤0.01% | 1376 |
|
|
2020
Q1 | $5K | Sell |
1,800
-849
| -32% | -$2.36K | ﹤0.01% | 1219 |
|
|
2019
Q4 | $10K | Buy |
2,649
+600
| +29% | +$2.27K | ﹤0.01% | 1244 |
|
|
2019
Q3 | $10K | Hold |
2,049
| – | – | ﹤0.01% | 1192 |
|
|
2019
Q2 | $12K | Hold |
2,049
| – | – | ﹤0.01% | 1254 |
|
|
2019
Q1 | $14K | Sell |
2,049
-300
| -13% | -$2.05K | ﹤0.01% | 1136 |
|
|
2018
Q4 | $20K | Sell |
2,349
-700
| -23% | -$5.96K | ﹤0.01% | 1105 |
|
|
2018
Q3 | $61K | Buy |
3,049
+500
| +20% | +$10K | ﹤0.01% | 880 |
|
|
2018
Q2 | $65K | Buy |
+2,549
| New | +$65K | 0.01% | 829 |
|
|
2018
Q1 | – | Sell |
-100
| Closed | -$3K | – | 2709 |
|
|
2017
Q4 | $3K | Sell |
100
-409
| -80% | -$12.3K | ﹤0.01% | 1916 |
|
|
2017
Q3 | $10K | Buy |
+509
| New | +$10K | ﹤0.01% | 1906 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3519 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3567 |
|
|
2016
Q4 | – | Sell |
-7,600
| Closed | -$124K | – | 3583 |
|
|
2016
Q3 | $124K | Sell |
7,600
-1,945
| -20% | -$31.7K | 0.01% | 1004 |
|
|
2016
Q2 | $144K | Buy |
+9,545
| New | +$144K | 0.01% | 832 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3569 |
|